Home › Merck Applauds the U.S. Department of Veterans Affairs (VA) for Broadening Treatment Access for Veterans with Chronic Hepatitis C Infection
 

Keywords :   


Merck Applauds the U.S. Department of Veterans Affairs (VA) for Broadening Treatment Access for Veterans with Chronic Hepatitis C Infection

2016-03-09 22:00:00| Merck.com - Corporate News

Dateline City: KENILWORTH, N.J. KENILWORTH, N.J.--(BUSINESS WIRE)--Merck (NYSE:MRK), known as MSD outside the United States and Canada, applauds the U.S. Department of Veterans Affairs (VA) for broadening access to treatment for Veterans with chronic hepatitis C virus (HCV) infection. Language: English Contact: MerckMedia:Pam Eisele, 267-305-3558Sarra Herzog, 201-669-6570orInvestors:Teri Loxam, 908-740-1986Amy Klug, 908-740-1898 Ticker Slug: Ticker: MRK Exchange: NYSE read more

Tags: with access department treatment

Category:Biotechnology and Pharmaceuticals

Latest from this category

All news
»
16.05Backlash as Morrisons trials sale of New Zealand lamb
16.05LRS Advances Aluminum Can Recovery with EverestLabs Robot, Funded by Can Manufacturers Institute
16.05Paramount selects Vubiquity to provide managed services for MTV Japan
16.05Waste Water Recycling Pilot Coming to Waterloo, Ontario, Canada
16.05New Rules Pending for Reuse And How Movers in This Space Are Doing
16.05Tageos opens RFID manufacturing site in North Carolina
16.05Net Sales Down 10.5% for Grove Collaborative in Q1 2024
16.05Xeikon and Sappi form \'sweet\' partnership
More »